146 related articles for article (PubMed ID: 16849321)
1. Structural determinants for cross-talk between pyruvate dehydrogenase kinase 3 and lipoyl domain 2 of the human pyruvate dehydrogenase complex.
Tso SC; Kato M; Chuang JL; Chuang DT
J Biol Chem; 2006 Sep; 281(37):27197-204. PubMed ID: 16849321
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.
Kato M; Chuang JL; Tso SC; Wynn RM; Chuang DT
EMBO J; 2005 May; 24(10):1763-74. PubMed ID: 15861126
[TBL] [Abstract][Full Text] [Related]
3. Marked differences between two isoforms of human pyruvate dehydrogenase kinase.
Baker JC; Yan X; Peng T; Kasten S; Roche TE
J Biol Chem; 2000 May; 275(21):15773-81. PubMed ID: 10748134
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex.
Tuganova A; Boulatnikov I; Popov KM
Biochem J; 2002 Aug; 366(Pt 1):129-36. PubMed ID: 11978179
[TBL] [Abstract][Full Text] [Related]
5. Lipoyl domain-based mechanism for the integrated feedback control of the pyruvate dehydrogenase complex by enhancement of pyruvate dehydrogenase kinase activity.
Ravindran S; Radke GA; Guest JR; Roche TE
J Biol Chem; 1996 Jan; 271(2):653-62. PubMed ID: 8557670
[TBL] [Abstract][Full Text] [Related]
6. Facilitated interaction between the pyruvate dehydrogenase kinase isoform 2 and the dihydrolipoyl acetyltransferase.
Hiromasa Y; Roche TE
J Biol Chem; 2003 Sep; 278(36):33681-93. PubMed ID: 12816949
[TBL] [Abstract][Full Text] [Related]
7. Ligand-induced effects on pyruvate dehydrogenase kinase isoform 2.
Hiromasa Y; Hu L; Roche TE
J Biol Chem; 2006 May; 281(18):12568-79. PubMed ID: 16517984
[TBL] [Abstract][Full Text] [Related]
8. The carboxy-terminal tail of pyruvate dehydrogenase kinase 2 is required for the kinase activity.
Klyuyeva A; Tuganova A; Popov KM
Biochemistry; 2005 Oct; 44(41):13573-82. PubMed ID: 16216081
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer.
Roche TE; Hiromasa Y
Cell Mol Life Sci; 2007 Apr; 64(7-8):830-49. PubMed ID: 17310282
[TBL] [Abstract][Full Text] [Related]
10. Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.
Kato M; Li J; Chuang JL; Chuang DT
Structure; 2007 Aug; 15(8):992-1004. PubMed ID: 17683942
[TBL] [Abstract][Full Text] [Related]
11. Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites.
Kolobova E; Tuganova A; Boulatnikov I; Popov KM
Biochem J; 2001 Aug; 358(Pt 1):69-77. PubMed ID: 11485553
[TBL] [Abstract][Full Text] [Related]
12. Specificity determinants for the pyruvate dehydrogenase component reaction mapped with mutated and prosthetic group modified lipoyl domains.
Gong X; Peng T; Yakhnin A; Zolkiewski M; Quinn J; Yeaman SJ; Roche TE
J Biol Chem; 2000 May; 275(18):13645-53. PubMed ID: 10788482
[TBL] [Abstract][Full Text] [Related]
13. Requirements for the adaptor protein role of dihydrolipoyl acetyltransferase in the up-regulated function of the pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase.
Yang D; Gong X; Yakhnin A; Roche TE
J Biol Chem; 1998 Jun; 273(23):14130-7. PubMed ID: 9603912
[TBL] [Abstract][Full Text] [Related]
14. Diversity of the pyruvate dehydrogenase kinase gene family in humans.
Gudi R; Bowker-Kinley MM; Kedishvili NY; Zhao Y; Popov KM
J Biol Chem; 1995 Dec; 270(48):28989-94. PubMed ID: 7499431
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate dehydrogenase kinase isoform 2 activity stimulated by speeding up the rate of dissociation of ADP.
Bao H; Kasten SA; Yan X; Hiromasa Y; Roche TE
Biochemistry; 2004 Oct; 43(42):13442-51. PubMed ID: 15491151
[TBL] [Abstract][Full Text] [Related]
16. Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase.
Korotchkina LG; Patel MS
J Biol Chem; 2001 Oct; 276(40):37223-9. PubMed ID: 11486000
[TBL] [Abstract][Full Text] [Related]
17. A new locus for X-linked dominant Charcot-Marie-Tooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene.
Kennerson ML; Yiu EM; Chuang DT; Kidambi A; Tso SC; Ly C; Chaudhry R; Drew AP; Rance G; Delatycki MB; Züchner S; Ryan MM; Nicholson GA
Hum Mol Genet; 2013 Apr; 22(7):1404-16. PubMed ID: 23297365
[TBL] [Abstract][Full Text] [Related]
18. Specific ion influences on self-association of pyruvate dehydrogenase kinase isoform 2 (PDHK2), binding of PDHK2 to the L2 lipoyl domain, and effects of the lipoyl group-binding site inhibitor, Nov3r.
Hiromasa Y; Yan X; Roche TE
Biochemistry; 2008 Feb; 47(8):2312-24. PubMed ID: 18220415
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional insights into the molecular mechanisms responsible for the regulation of pyruvate dehydrogenase kinase 2.
Green T; Grigorian A; Klyuyeva A; Tuganova A; Luo M; Popov KM
J Biol Chem; 2008 Jun; 283(23):15789-98. PubMed ID: 18387944
[TBL] [Abstract][Full Text] [Related]
20. Partial activation of the pyruvate dehydrogenase kinase by the lipoyl domain region of E2 and interchange of the kinase between lipoyl domain regions.
Ono K; Radke GA; Roche TE; Rahmatullah M
J Biol Chem; 1993 Dec; 268(35):26135-43. PubMed ID: 8253731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]